Joincare Pharmaceutical Group Industry Co (SHSE:600380) Debt-to-Equity : 0.36 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Debt-to-Equity?

Joincare Pharmaceutical Group Industry Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,758 Mil. Joincare Pharmaceutical Group Industry Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,355 Mil. Joincare Pharmaceutical Group Industry Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥14,235 Mil. Joincare Pharmaceutical Group Industry Co's debt to equity for the quarter that ended in Mar. 2024 was 0.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Joincare Pharmaceutical Group Industry Co's Debt-to-Equity or its related term are showing as below:

SHSE:600380' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.36 Max: 0.58
Current: 0.36

During the past 13 years, the highest Debt-to-Equity Ratio of Joincare Pharmaceutical Group Industry Co was 0.58. The lowest was 0.03. And the median was 0.36.

SHSE:600380's Debt-to-Equity is ranked worse than
55.07% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs SHSE:600380: 0.36

Joincare Pharmaceutical Group Industry Co Debt-to-Equity Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Debt-to-Equity Chart

Joincare Pharmaceutical Group Industry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.26

0.22

0.29

0.42

0.43

Joincare Pharmaceutical Group Industry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.44	0.47	0.44	0.43	0.36

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joincare Pharmaceutical Group Industry Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Debt-to-Equity falls into.

Joincare Pharmaceutical Group Industry Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Joincare Pharmaceutical Group Industry Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2794.723	+	3137.696)	/	13755.902
	=	0.43

Joincare Pharmaceutical Group Industry Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2757.638	+	2354.699)	/	14234.87
	=	0.36

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Joincare Pharmaceutical Group Industry Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057

Website

http://www.joincare.com

Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.

Executives

Yu Xiong	Directors, senior managers
Zhao Feng Guang	senior management
Qiu Qing Feng	Directors, senior managers
Tang Ling Zhi	senior management
Lin Nan Qi	Directors, senior managers
Cao Ping Wei	Director
Feng Yan Fang	Director
Zhong Shan	senior management
Yang Dong Yun	senior management
Peng Jin Hua	Supervisors
Xie You Guo	Supervisors
Guo Xiao Yun	Supervisors
Su Qing Wen	senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines